Cesari Rossano - Pfizer Inc | 人才画像

基本信息

浏览量：14

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 23 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

TABLE 3 from First-line Avelumab Plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study

Duncan Wheatley,Rossana Berardi, Miguel Ángel Climent Durán,Anna Tomiak, Alastair Greystoke, Anthony M. Joshua, Hendrik‐Tobias Arkenau,Lajos Géczi,Javier Garciá Corbacho,Luis Paz‐Ares,Syed A. Hussain, Luboš Petruželka,Angelo Delmonte,Colombe Chappey,Joanna C. Masters,Elisabete Michelon,Danielle A. Murphy, Sandrine Mwewa,Rossano Cesari,Bernard Doger

openalex（2024）

引用0浏览0引用

FIGURE 1 from First-line Avelumab Plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study

openalex（2024）

引用0浏览0引用

FIGURE 2 from First-line Avelumab Plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study

openalex（2024）

引用0浏览0引用

First-line Avelumab Plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase 1b/2 JAVELIN Chemotherapy Medley Study

Duncan Wheatley,Rossana Berardi, Miguel Ángel Climent Durán,Anna Tomiak,Alastair Greystoke, Anthony M. Joshua,Hendrik‐Tobias Arkenau,Lajos Géczi,Javier Garciá Corbacho, Luis Paz‐Ares,Syed A. Hussain,Luboš Petruželka,Angelo Delmonte,Colombe Chappey,Joanna C. Masters,Elisabete Michelon,Danielle A. Murphy, Sandrine Mwewa,Rossano Cesari,Bernard Doger

Cancer research communications (2024)

引用0浏览0引用

Supplementary Data from First-line Avelumab Plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study

Duncan A Wheatley, Rossana Berardi, Miguel A Climent Duran,Anna Tomiak, Alastair P Greystoke,Anthony M Joshua,Hendrik-Tobias Arkenau,Lajos Géczi,Javier Garciá Corbacho, Luis G Paz-Ares,Syed A Hussain,Lubos Petruželka,Angelo Delmonte,Colombe Chappey,Joanna C Masters,Elisabete Michelon,Danielle A Murphy, Sandrine Mwewa,Rossano Cesari,Bernard Doger de Spéville

openalex（2024）

引用0浏览0WOS引用

Supplemental Figure S1 and Figure S2. from A Phase I, Dose-Finding Study in Patients with Advanced Solid Malignancies of the Oral Γ-Secretase Inhibitor PF-03084014

Wells A. Messersmith,Geoffrey I. Shapiro,James M. Cleary, Antonio Jimeno,Arvind Dasari,Bo Huang,M. Naveed Shaik,Rossano Cesari, Xiufen Zheng,Jennifer M. Reynolds,Patricia A. English,Karen R. McLachlan,Kenneth A. Kern,Patricia LoRusso

openalex

引用0浏览0引用

Supplementary Tables and Figures from Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer

Neil H. Segal,Aiwu R. He,Toshihiko Doi,Ronald Levy,Shailender Bhatia,Michael J. Pishvaian,Rossano Cesari, Ying Chen, Craig B. Davis,Bo Huang,Aron D. Thall,Ajay K. Gopal

crossref（2023）

引用0浏览0引用

Supplemental Table S1. from A Phase I, Dose-Finding Study in Patients with Advanced Solid Malignancies of the Oral Γ-Secretase Inhibitor PF-03084014

Wells A. Messersmith,Geoffrey I. Shapiro,James M. Cleary,Antonio Jimeno, Arvind Dasari,Bo Huang,M. Naveed Shaik,Rossano Cesari,Xianxian Zheng,Jennifer M. Reynolds,Patricia A. English,Karen R. McLachlan,Kenneth A. Kern,Patricia M. LoRusso

openalex（2023）

引用0浏览0引用

Optimizing Outcomes for High-Risk, Non-Muscle-invasive Bladder Cancer: the Evolving Role of PD-(L)1 Inhibition

Jens Bedke, Peter C Black,Bernadett Szabados, Félix Guerrero-Ramos,Shahrokh François Shariat,Evanguelos Xylinas,Julia Brinkmann, John A Blake-Haskins,Rossano Cesari,Joan Palou Redorta

Urologic oncologyno. 12 (2023): 461-475

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn